Clinical trials
Heart Diseases trials in Norway
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 2 |
| 2010 | 4 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2016 | 5 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 23 |
| Active, not recruiting | 4 |
| Unknown status | 4 |
| Recruiting | 2 |
| Terminated | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Oslo University Hospital | 8 |
| Norwegian University of Science and Technology | 5 |
| Helse Nord-Trøndelag HF | 4 |
| Medtronic Cardiac Rhythm and Heart Failure | 2 |
| St. Olavs Hospital | 2 |
| University Hospital, Akershus | 2 |
| Asker & Baerum Hospital | 1 |
| AstraZeneca | 1 |
| CSL Behring | 1 |
| Cardiaccs AS | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Diseases | 36 |
| Cardiovascular Diseases | 12 |
| Heart Failure | 9 |
| Atrial Fibrillation | 4 |
| Myocardial Infarction | 4 |
| Pathologic Processes | 3 |
| Acute Coronary Syndrome | 2 |
| Aortic Diseases | 2 |
| Arrhythmias, Cardiac | 2 |
| Atherosclerosis | 2 |
Trials
Showing 26 to 36 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.